Tag: Pain
-
Mediaplanet features International Pain Foundation for pain month issue
We recently participated in Mediaplanet’s “Pain and Sleep Sensitivity” campaign where we united with like-minded industry leaders to educate the public on the importance of getting a good night’s sleep to mental, heart and immune system health. The campaign was distributed through USA TODAY on August 19th 2016 and is published online. For the full…
-
Study for severe to very severe COPD patients
New Study for People with Severe to Very Severe COPD This research study is testing whether a new investigational drug that targets eosinophils (a type of white blood cell) could help patients with COPD (chronic obstructive pulmonary disease) control symptoms and reduce exacerbations (flare-ups) that lead to hospitalizations. The new investigational drug will be compared to…
-
The Pain Experience: Meeting the Needs of Pain Patients by Stephanie Lynn Christianson
The Pain Experience: Meeting the Needs of Pain Patients by Stephanie Lynn Christianson Executive Summary Pain is difficult to define with certainty. Healthcare professionals are confronted with a high degree of complexity which affect the standards of care. The International Association for the Study of Pain (IASP) defines pain as, “An unpleasant sensory and emotional…
-
Michigan Pain Survivor—Learning a New “Normal” By Karen Shay
Michigan Pain Survivor—Learning a New “Normal” By Karen Shay Editor’s Note: Karen Shay spent 23 years practicing in Occupational Therapy as a treating therapist with patients with multiple types of disorders and diagnoses, as well as a manager. After two cervical spine surgeries and one lumbar surgery, resulting in nerve damage adding to the already…
-
MOVANTIK™ (naloxegol) tablets for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain launched in the US
MOVANTIK™ (naloxegol) tablets for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain launched in the US Tuesday, 31 March 2015 AstraZeneca (NYSE: AZN) announced today that MOVANTIK™ (naloxegol) has launched in the United States. On September 16, 2014, the US Food and Drug Administration (FDA) approved MOVANTIK as the first once-daily…